These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34437568)

  • 41. DVT incidence and risk factors in critically ill patients with COVID-19.
    Chen S; Zhang D; Zheng T; Yu Y; Jiang J
    J Thromb Thrombolysis; 2021 Jan; 51(1):33-39. PubMed ID: 32607652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.
    Nossent EJ; Schuurman AR; Reijnders TDY; Saris A; Jongerius I; Blok SG; de Vries H; Duitman J; Vonk Noordegraaf A; Meijboom LJ; Lutter R; Heunks L; Bogaard HJ; van der Poll T
    Front Immunol; 2021; 12():664209. PubMed ID: 34054832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China.
    Sun JK; Liu Y; Zou L; Zhang WH; Li JJ; Wang Y; Kan XH; Chen JD; Shi QK; Yuan ST
    World J Gastroenterol; 2020 Oct; 26(39):6087-6097. PubMed ID: 33132657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?
    Gómez-Pastora J; Weigand M; Kim J; Wu X; Strayer J; Palmer AF; Zborowski M; Yazer M; Chalmers JJ
    Clin Chim Acta; 2020 Oct; 509():249-251. PubMed ID: 32579952
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China.
    Ma S; Lai X; Chen Z; Tu S; Qin K
    Int J Infect Dis; 2020 Jul; 96():683-687. PubMed ID: 32470606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
    Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
    Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
    Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
    Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients.
    Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series.
    Tabatabai A; Rabin J; Menaker J; Madathil R; Galvagno S; Menne A; Chow JH; Grazioli A; Herr D; Tanaka K; Scalea T; Mazzeffi M
    A A Pract; 2020 May; 14(7):e01236. PubMed ID: 32539272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
    Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
    Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.
    Kalicińska E; Szymczak D; Zińczuk A; Adamik B; Smiechowicz J; Skalec T; Nowicka-Suszko D; Biernat M; Bogucka-Fedorczuk A; Rybka J; Martuszewski A; Gozdzik W; Simon K; Wróbel T
    Cells; 2021 May; 10(6):. PubMed ID: 34071149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of severe acute respiratory syndrome coronavirus 2 in nasopharynx according to clinical phenotype of affected patients.
    Valent F; Di Chiara A
    Clin Microbiol Infect; 2020 Dec; 26(12):1686.e1-1686.e4. PubMed ID: 32905833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of artificial liver blood purification treatment on the survival of critical ill COVID-19 patients.
    Dai X; Zhang Y; Yu L; Jiang YA; Chen L; Chen Y; Li M; Gao C; Shang J; Xiang S; Li Y; Li J; Zhou C; Zhou X; Chen N; Liu Y; Liu J; Zhang Y; Chen X; Zhu D; Gao H; Tang L; Zhu M; Li L
    Artif Organs; 2021 Jul; 45(7):762-769. PubMed ID: 33326621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients.
    Ilias I; Diamantopoulos A; Botoula E; Athanasiou N; Zacharis A; Tsipilis S; Jahaj E; Vassiliou AG; Vassiliadi DA; Kotanidou A; Tsagarakis S; Dimopoulou I
    Front Endocrinol (Lausanne); 2021; 12():644055. PubMed ID: 34220703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients.
    Dupont T; Caillat-Zucman S; Fremeaux-Bacchi V; Morin F; Lengliné E; Darmon M; Peffault de Latour R; Zafrani L; Azoulay E; Dumas G
    Chest; 2021 May; 159(5):1884-1893. PubMed ID: 33316234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients.
    Archambault AS; Zaid Y; Rakotoarivelo V; Turcotte C; Doré É; Dubuc I; Martin C; Flamand O; Amar Y; Cheikh A; Fares H; El Hassani A; Tijani Y; Côté A; Laviolette M; Boilard É; Flamand L; Flamand N
    FASEB J; 2021 Jun; 35(6):e21666. PubMed ID: 34033145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thromboelastography findings in critically ill COVID-19 patients.
    Salem N; Atallah B; El Nekidy WS; Sadik ZG; Park WM; Mallat J
    J Thromb Thrombolysis; 2021 May; 51(4):961-965. PubMed ID: 33011896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.